About
CRPN serves clinical sites to ensure they have everything they need to perform quality clinical research - when they need it.
A great divide between healthcare and research industries lies in financial misinterpretation. Most of the healthcare industry does not speak the research industry's language of fixed contracts, legal agreements, and invoices. Rather, healthcare more readily understands adjusted fee schedules, insurance claims, and payer mixes. Consequently, new generations of physicians are discouraged from researching and clinical sites are closing permanently due to catastrophic financial dysfunction.
​
The Clinical Research Payment Network (CRPN) offers a financial solution that translates clinical research environments into business practices that are routinely accepted by the healthcare industry. As a result, CRPN empowers physicians and clinical sites to perform research without the current financial stresses of the industry. Our streamlined financial models also allow sponsors and CROs to focus on the proper management and quality of trials in lieu of cumbersome financial obstacles.
​
Mission
CRPN will empower efficient translational research by aligning the clinical research industry's financial compensation models with the needs of healthcare environments. Together, CRPN, its partners, and its members will bridge the financial gaps between research and healthcare environments, improve current and future patient care, and advance medicine as safely and efficiently as possible.
Background
CRPN’s concept was founded by Dr. Daniel Fox, who as a Director of Clinical Research with global pharmaceutical development experience, observed significant financial disparities between the clinical research industry and a healthcare environment. If we can resolve our industries' financial differences, sites no longer have to develop and maintain tailored clinical research billing systems, physicians will be paid timely and remain motivated to participate as active investigators, sponsors will execute, perform, and complete research in record time, and innovative therapies will ultimately translate to patient care with greater efficiency and quality.
Administration
CRPN’s executive team comprises years of experience in managed care, clinical research, and demonstrated leadership:
Dr. Daniel Fox is a translational scientist with almost 20 years of scientific experience and over 15 years of administrative leadership experience ranging from small biotech startups to global pharmaceutical program management. Daniel has successfully led and administered research operations in academic, industry, pharmaceutical manufacturing, sponsor, and clinical research site environments. He is also the co-founder, president, and current CRO of a 501(c)(3) autism nonprofit association.
​
Daniel holds a Masters Degree in Public Health and PhD in pharmacology and neuroscience from Southern Illinois University. He served as a manager and auditor at a military site during his post-doctoral studies to assess the safety and efficacy of pharmacological otoprotectants in drill sargent trainees. Following his post-doctoral studies, Daniel traveled to the east coast to manage small biotech development, ventured to the west cost to work in pharmaceutical manufacturing at the global manufacturing organization Catalent, and finally returned to the midwest where he administered clinical trials for the second largest multi-specialty clinic in the state. Daniel resigned as a director of research at a single site to focus full time on developing CRPN as the industry standard for clinical research business compliance, accountability, and professionalism.
​
Daniel Fox, MPH, PhD
Founder/CEO
Advisory Board
CRPN's mission is growing. As we grow, some of our industry's innovative and passionate leaders are helping us to develop the organization with the revolutionary operations we need to instill lasting change. Thank you to our advisory board for contributing your knowledge, expertise, and guidance to help our mission grow in the industry.
Mary Costello has spent over thirty years in the healthcare and clinical research fields, working in commercial leadership roles with large organizations including Covance, Thermo Fisher, and, more recently, supporting the growth and expansion of eClinical Solutions and Elligo Health Research. Costello has served on several industry advisory groups and is a founder and board member of BioAustin. At Medable, she serves as Head of the Site and Investigator Network and is passionate about ensuring the site’s voice and experience help shape improvements to the clinical research industry.
​
Mary brings decades of commercial and marketing experience to CRPN's board of advisors to help it grow and advance throughout the industry.
Mary Costello
Business Development and Marketing
Edye Edens,
JD, MA, CIP, CCRP
Research Compliance
Edye Edens is a licensed attorney with a background in international human rights, research ethics, and health law. She completed her MA in International Research Ethics in 2012, she worked the program manager for an NIH grant for international institutional review boards partnering in Kenya, she is a Certified IRB Professional (CIP,) Certified Clinical Research Professional (CCRP), and she holds a green belt certification in lean six sigma. Ms. Edens also teaches at Indiana Univerity's McKinney School of Law and oversees the Hall Center for Law and Health Externship Program.
​
Her consulting services include research administration, healthcare compliance, grants/contracts to IRB(s), COI, education, privacy, HIPAA, multiple areas of FDA compliance related to drugs, devices, and food; AAHRPP misconduct and site-level compliance work as it relates to QA, monitoring, and auditing (particularly oncology. Services provided include education and training, program creation and management, and/or complete outsourcing solutions. Ms. Edens also publishes and speaks regularly at regional and national professional research and compliance association meetings, including HCCA, SCCE, PRIM&R, MAGI, AAHRPP, SPARC, RAPS, and AHLA.
​
Edye has agreed to bring her experience to CRPN's board of advisors as an industry expert in research compliance and regulatory operations.
Robert Goldman, MD
Sponsor Operations
Dr. Robert Goldman is an industry leader with over 10 years of medical education and over 12+ years of combined experience in clinical research operations and top-tier CRO experience. He has a broad range of therapeutic area experiences with a passion for Analgesia, CNS, Respiratory, Gastroenterology, Endocrinology, and Oncology.
Robert holds an undergraduate degree from Michigan State University in Medical Technology and Laboratory Sciences, A Masters degree in Basic Medical Sciences from Wayne State University, and a Doctor of Medicine from St. Matthews University School of Medicine in Grand Cayman, British West Indies. Robert is now a proven leader in the industry holding numerous leadership titles including Clinical Research Associate, Sr. Clinical Research Associate, Visit Leader, Clinical Team/Trial Manager, Project Manager, Associate Director and Director of Clinical Operations.
While in medical school, Robert participated in pharmaceutical educational research studies and attended several conferences with the world congress of infectious disease in obstetrics and gynecology. Following completion of pre-clinical training in South Miami and his USMLE examinations (Step 1, Step 2 CK and CS), Robert decided to take an alternative professional route. He entered clinical research at the site level and then quickly entered the industry at the CRO level. Currently, he is a Director of Operations at the sponsor level leading pivotal studies for his company's lead asset.
​
Robert's is working with CRPN's board of advisors to bring his knowledge, experience, and vision to the forefront of industry innovation. His site-, CRO-, and Sponsor-facing perspectives will help CRPN develop offerings that will revolutionize how we perform clinical research business operations.
Henry Kravchenko
Business, IT, and Data Analytics
Henry Kravchenko is the founder and CEO of Clinical.ly, a technology company with the mission to deliver clinical research software that puts you in control. Clinical.ly works closely with the research community to understand its challenges and integrate its feedback into Clinical.ly's intuitive, web-based technology solutions.
Before founding Clinical.ly, Henry spent over two decades working with Hedge Funds. He led technology teams responsible for high-tech solutions ranging from risk analytics to regulatory compliance and large-scale trading systems. Henry holds a Microsoft Certified System Engineer Certification and Chartered Alternative Investment Analyst Designation. Henry graduated from Brooklyn College, earning a B.S. in Computer Information Science, and obtained a business degree from Stanford University Graduate School of Business.
Henry brings to CRPN's board of advisors a unique combined experience of IT development, Data Analytics, and Business Investment strategies that will help the organization develop the best possible solutions in the industry, create validated and trustworthy metrics, and explore investment options that will best fit CRPN's strategies and expansion needs.
​
​
Beverly Roy, PhD
Site/Regulatory Operations and
Data Analytics
Chris Sauber
Site Contracts and Budget Negotiations
Dr. Beverly Roy is a clinical research leader with over 10 years of experience in both academic and industry clinical research settings. Bev worked at the University of Oklahoma Health Sciences Center as a Clinical Research Administrator, the Cancer Treatment Centers of America as a Regulatory Specialist, the Mercy Hospital Systems as a Director of Clinical Research, and as a Director of Clinical Validation in a small sponsor setting.
Bev holds a PhD from Capella University, an MHR from University of Oklahoma, and she is a formal statistician by training with certifications in big data modeling, management systems, machine learning, and integration/processing. Bev has also served on various committees and has presented research at numerous professional research conferences and has co-chaired The Cure Club for the Muscular Dystrophy Association.
Bev brings to CRPN's advisory board years of experience in clinical site and regulatory operations combined with an analytical point of view to ensure the organization strives for validated, measurable, and accountable processes designed and tested to improve the clinical research industry.
​
​
​
Chris Sauber is a former study coordinator and now a successful clinical research site owner.
​
While Chris continues to operate as a site owner, he also specializes in consulting work to help interested industry professionals establish their research sites and occasionally CROs and Sponsors meet their research needs.
​
Chris has performed many different roles in his research tenure, including CRC, site director, site owner, CRA, auditor, consultant, and project manager.
​
Chris brings to CRPN's Board of Advisors successful industry in contract and budget negotiations, successful site operative logistics, and the priceless "site-level opinion" needed to develop this industry into a positive and productive translational science environment.
​
​
​
Peter Fredette has over 25 years experience in drug development, pre-clinical and clinical research. Peter’s deepest experience is in oncology therapeutic clinical research however, it extends to all phases of drug development, across many therapeutic areas. He is passionate about clinical trials as a care option for patients, and building long-term alliances that bring research professionals and patients closer together.
Peter Fredette
CRO Operations
Community
CRPN was founded to serve our community. We proudly work to ensure our mission continues.
CRPN is a proud member of the Save Our Sites Alliance. Together, sites, sponsors, and vendors alike can come together, talk about our challenges, and do something accomplish positive and progressive change in our industry. Join SOS across social media and at its conferences today.
CRPN is honored to partner with Imagebloom to bring our site partners the best possible patient recruitment and advertisement experience our industry can offer. Together, we are working throughout the industry to bring sites, sponsors, and patients optimal advertising experiences for positive, productive, and efficient trial performance.
CRPN proudly supports Clinical.ly - The Clinical Research Software company that puts you, the site, in control. Clinical.ly's novel clinical research technology partners with research sites and sources new ideas directly from research industry practitioners. Contact the team today.
Dr. Fox is a proud member of Innovate in What You Do's Subject Matter Expert Network. IIWYD empoewrs Pharma, BioTech, and Clinical Research companies to be their best, and CRPN is honored to serve our industry to help them translate technologies to our patients as quickly, safely, and efficiently as possible.
CRPN partners with Yendou to offer our clinical site network an optimal study startup and feasibility experience. Yendou's global platform is designed to accelerate medical advancement by delivering clinical trials to physicians and patients, universally, as soon as possible. Visit the website and register today to revolutionize your business development strategies.
CRPN is honored to partner with MedVector to offer our sites and the patients we serve an optimal clinical research experience. We all know a local specialist that should be referring patients to clinical trials, but isn't. medVector's site utility engages these local physicians and encourages referrals to trial PIs via remote and virtual solutions. Contact the team today or visit their website to learn more about how MedVector is expanding patient access beyond clinical trial sites.
CRPN is a proud and active member of the Society for Clinical Research sites. Together, we can voice our concerns and accomplish progressive change in the clinical research industry.
CRPN is officially certified as an Autism Conscious Environment by Innovation Autism. We are a proud support of neurodiversity and work to build our business environments around all our community's needs.